MLEC·Luxembourg·Healthcare
Share

Moolec Science SA

$ 0.61

Moolec Science SA

Share
MLEC·Luxembourg·Healthcare

$ 0.61

Rating

1

Buy

Risk factor

Very high price volatility

Very poor trading liquidity

Weak & very vulnerable to price shocks

Profitability factor

Greatly overvalued vs peers

Very low or no dividends

Very poor margins and returns

Risk / Profitability

Risk: High

Profitability: Poor

Risk factor

Very high price volatility

Very poor trading liquidity

Weak & very vulnerable to price shocks

Profitability factor

Greatly overvalued vs peers

Very low or no dividends

Very poor margins and returns

$ 0.61

About

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South...

About

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

About

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

About

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.